MedPath

山东仁和制药有限公司

Ownership
-
Established
2001-10-10
Employees
-
Market Cap
-
Website
http://www.chinarenhe.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

复方天麻颗粒

Approval Number
国药准字Z20093366
Approval Date
Feb 28, 2024
NMPA

元胡止痛片

Approval Number
国药准字Z37020452
Approval Date
Jun 15, 2023
NMPA

Aspirin Tablets

Product Name
阿司匹林片
Approval Number
国药准字H37022276
Approval Date
Jun 15, 2023
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H37021093
Approval Date
Jun 15, 2023
NMPA

Erythromycin Enteric-coaded Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H37021099
Approval Date
Jun 15, 2023
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H37021094
Approval Date
Jun 15, 2023
NMPA

Chondroitin Sulfate Sodium Tablets

Product Name
硫酸软骨素钠片
Approval Number
国药准字H37021095
Approval Date
Jun 15, 2023
NMPA

维C银翘片

Approval Number
国药准字Z37020454
Approval Date
Jun 15, 2023
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H37021096
Approval Date
Jun 15, 2023
NMPA

Meleumycin Tablets

Product Name
麦白霉素片
Approval Number
国药准字H37023634
Approval Date
Jun 15, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath